Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03136406
Recruitment Status : Active, not recruiting
First Posted : May 2, 2017
Last Update Posted : August 12, 2020
Information provided by (Responsible Party):
ImmunityBio, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : April 2021